Few undergraduate students can lay claim to discovering a virus, but IU Southeast’s Drew Gukeisen is one of them. In a sample of water from the Ohio River near Jeffersonville, Ind., Gukeisen recently found a bacteriophage — a virus that invades bacteria — that has since been named OHR. This particular “phage” invades a bacteria… Read more »
Tag: Life Sciences
Digital approach by IU dental resident, IUPUI team restores Evansville man's lower face
Back in 1997, Evansville mechanic Shirley Anderson developed tongue cancer. The radiation treatment worked — at least for a time — as he thought was cancer free after 15 years had passed. But the cancer returned in 2012 and this time, the severe side effects of radiation therapy destroyed Anderson’s mandible. After several unsuccessful attempts… Read more »
IU scientist's use of decoy proteins to boost plant immunity offers huge economic potential
In the latest issue of the academic journal Science, IU Professor Roger Innes and a team of researchers within IU Bloomington’s Department of Biology describe how a minor alteration to an existing plant gene could set the stage for making future plants more resistant to a broad range of diseases. This approach — which marks… Read more »
Deadline for CTSI's post-doc training awards in translational research is Feb. 29; additional translational awards carry March 4 deadline
A deadline of Feb. 29 is set for applicants seeking the Indiana Clinical and Translational Sciences Institute’s (CTSI) special post-doctoral training award in translational research. The award offers post-doctoral research associates at Indiana University, Purdue University and the University of Notre Dame experience in writing and reviewing proposals related to translational research — or the… Read more »
Concussion detection device developed by IU optometry professors recently featured in TV segment aired on Evansville's WFIE-14News
A portable device being developed by Indiana University optometry professors Nicholas Port and Steven Hitzeman to quickly detect concussion symptoms in athletes was featured this week on Evansville’s NBC affiliate, WFIE-14News. To measure concussion symptoms, Port and Hitzeman devised a system that includes eye-tracking goggles within a shoebox-sized device and a balance platform based on… Read more »
How do disruptive health care, life science business models affect innovation? Find out on Feb. 19 at Kelley School session in Indy
As the healthcare industry’s “fee for service” model gradually gives way to revenues generated through outcomes and agreements focused on wellness and prevention, how will this impact the development of innovative new products and intellectual property? To gain a better grasp on this dilemma, the Center for the Business of Life Sciences at IU’s Kelley… Read more »
IU ranked among world's 50 most innovative universities, based on patent, publishing data
According to a Reuters News analysis of patent and publishing data from hundreds of research institutions around the globe between 2008 and 2013, Indiana University ranks among the world’s 50 most innovative universities. IU placed 49th in the list of Top 100 World’s Most Innovative Universities and 33rd among U.S. universities. Twelve of the Top 100, including… Read more »
Innovate Indiana to host trip bringing Monroe County, Evansville economic officials together
Innovate Indiana officials will host a Thursday meeting in Evansville that brings together economic development leaders in Monroe County with their counterparts in the River City. Monroe County officials will travel along the new I-69 corridor that links the two cities to tour innovation facilities at the University of Southern Indiana, while Evansville officials brief… Read more »
Biotech company with strong IU, Indiana ties adds execs ahead of anticipated clinical trials
Assembly Biosciences, a biotechnology company with strong Indiana University and Hoosier State ties that seeks to cure hepatitis B and C. difficile infections, announced several senior-level hires throughout the company on Monday. Founded in 2012, Assembly is largely built around the research of Adam Zlotnick, a professor of molecular and cellular biochemistry at Indiana University… Read more »
Article details IURTC's efforts to help bring an IU researcher's antibiotic derivative to market
Back in mid-2015, the Indiana University Research and Technology Corp. struck a deal with California-based La Jolla Pharmaceutical Co. to acquire intellectual property rights to “next-generation” offshoots of gentamicin — a hospital-grade antibiotic which has limited use because of its toxicity. Because the offshoots have shown signs of lacking such toxicity, they hold promise in… Read more »